Treatment of lupus

LupuzorTM may become the first specific and non-immunosuppressant therapy for lupus, a disabling autoimmune disease that is currently incurable. This peptide is the subject of a patent (granted in 2009) and has already successfully completed phases I and II of its regulatory clinical trials.
Source: ScienceDaily Headlines - Category: Science Source Type: news